Aberdeen Group plc Has $63.01 Million Position in American Healthcare REIT, Inc. $AHR

Aberdeen Group plc increased its holdings in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 24.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,338,967 shares of the company’s stock after purchasing an additional 263,791 shares during the period. Aberdeen Group plc owned approximately 0.76% of American Healthcare REIT worth $63,012,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. increased its holdings in American Healthcare REIT by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 23,529,739 shares of the company’s stock worth $988,484,000 after purchasing an additional 611,809 shares in the last quarter. State Street Corp lifted its stake in American Healthcare REIT by 6.5% in the 2nd quarter. State Street Corp now owns 6,902,944 shares of the company’s stock valued at $255,289,000 after acquiring an additional 422,931 shares in the last quarter. Invesco Ltd. boosted its position in American Healthcare REIT by 15.9% during the 2nd quarter. Invesco Ltd. now owns 5,820,530 shares of the company’s stock worth $213,846,000 after acquiring an additional 798,075 shares during the last quarter. Alliancebernstein L.P. boosted its position in American Healthcare REIT by 16.7% during the 2nd quarter. Alliancebernstein L.P. now owns 5,318,866 shares of the company’s stock worth $195,415,000 after acquiring an additional 759,501 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in shares of American Healthcare REIT by 11.1% during the 3rd quarter. American Century Companies Inc. now owns 2,838,692 shares of the company’s stock worth $119,254,000 after acquiring an additional 282,692 shares in the last quarter. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Stock Performance

NYSE AHR opened at $48.08 on Friday. The firm has a 50-day moving average of $50.16 and a 200-day moving average of $47.53. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.41 and a current ratio of 0.41. The stock has a market cap of $9.04 billion, a PE ratio of 117.26, a P/E/G ratio of 1.76 and a beta of 1.19. American Healthcare REIT, Inc. has a 52-week low of $26.48 and a 52-week high of $54.67.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.40). The company had revenue of $604.08 million during the quarter, compared to the consensus estimate of $617.49 million. American Healthcare REIT had a net margin of 3.09% and a return on equity of 2.57%. The firm’s revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.40 earnings per share. American Healthcare REIT has set its FY 2026 guidance at 1.990-2.050 EPS. On average, sell-side analysts anticipate that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.

American Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 17th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.25 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.00 annualized dividend and a yield of 2.1%. American Healthcare REIT’s dividend payout ratio (DPR) is presently 243.90%.

Insider Activity

In other American Healthcare REIT news, EVP Mark E. Foster sold 2,000 shares of American Healthcare REIT stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $48.55, for a total value of $97,100.00. Following the completion of the sale, the executive vice president owned 56,121 shares in the company, valued at $2,724,674.55. The trade was a 3.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.92% of the company’s stock.

Analysts Set New Price Targets

AHR has been the topic of a number of recent research reports. Zacks Research downgraded shares of American Healthcare REIT from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 1st. Jefferies Financial Group reiterated a “buy” rating on shares of American Healthcare REIT in a research note on Monday, December 15th. BMO Capital Markets assumed coverage on shares of American Healthcare REIT in a research note on Thursday, January 29th. They set an “outperform” rating and a $55.00 price objective for the company. Scotiabank lifted their target price on American Healthcare REIT from $55.00 to $59.00 and gave the company a “sector outperform” rating in a research report on Wednesday, March 11th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of American Healthcare REIT in a report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and a consensus target price of $53.67.

American Healthcare REIT Company Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.